
Sign up to save your podcasts
Or


Stay updated on recently FDA-approved medications crucial for pharmacists.
Gain essential insights on new drugs approved in the last 12 to 18 months, ensuring accurate dispensing and effective patient education.
The GameChanger
SweatControl Patch approved for primary axillary hyperhidrosis.
Update in treatment for Alzheimer's with mild cognitive impairment.
Host
Joe Strain, PharmD
Clinical Faculty, Monument Health
South Dakota State College of Pharmacy
Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the therapeutic indications of recent FDA-approved medications.
2. Describe unique pharmacological properties for each new medication.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-098-H01-P
Initial release date: 03/11/2024
Expiration date: 03/11/2025
Additional CPE details can be found here.
Follow CEimpact on Social Media:
LinkedIn
Instagram
By CEimpact4.8
1717 ratings
Stay updated on recently FDA-approved medications crucial for pharmacists.
Gain essential insights on new drugs approved in the last 12 to 18 months, ensuring accurate dispensing and effective patient education.
The GameChanger
SweatControl Patch approved for primary axillary hyperhidrosis.
Update in treatment for Alzheimer's with mild cognitive impairment.
Host
Joe Strain, PharmD
Clinical Faculty, Monument Health
South Dakota State College of Pharmacy
Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the therapeutic indications of recent FDA-approved medications.
2. Describe unique pharmacological properties for each new medication.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-098-H01-P
Initial release date: 03/11/2024
Expiration date: 03/11/2025
Additional CPE details can be found here.
Follow CEimpact on Social Media:
LinkedIn
Instagram

37,636 Listeners

38,856 Listeners

260 Listeners

4,743 Listeners

87,529 Listeners

3,360 Listeners

111,948 Listeners

37 Listeners

56,508 Listeners

172 Listeners

13,337 Listeners

3,678 Listeners

35 Listeners

32 Listeners

3 Listeners